This page shows the publications co-authored by Arash Mostaghimi and Daniela Kroshinsky.
Use of teledermatology by dermatology hospitalists is effective in the diagnosis and management of inpatient disease. J Am Acad Dermatol. 2021 Jun; 84(6):1547-1553.
The ALT-70 cellulitis model maintains predictive value at 24 and 48 hours after presentation. J Am Acad Dermatol. 2019 Dec; 81(6):1252-1256.
A predictive model for diagnosis of lower extremity cellulitis: A cross-sectional study. J Am Acad Dermatol. 2017 Apr; 76(4):618-625.e2.
Costs and Consequences Associated With Misdiagnosed Lower Extremity Cellulitis. JAMA Dermatol. 2017 Feb 01; 153(2):141-146.
Long-term Physical and Psychological Outcomes of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. JAMA Dermatol. 2021 06 01; 157(6):712-715.
Revenue generation of dermatology inpatient consultations: A retrospective multi-institutional evaluation of academic hospital-based consults. J Am Acad Dermatol. 2021 Jul; 85(1):275-276.
Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults. J Am Acad Dermatol. 2020 Jun; 82(6):1553-1567.
A survey-based study of diagnostic and treatment concordance in standardized cases of cellulitis and pseudocellulitis via teledermatology. J Am Acad Dermatol. 2020 05; 82(5):1221-1223.
Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10. JAMA Dermatol. 2019 04 01; 155(4):448-454.
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States. J Invest Dermatol. 2018 11; 138(11):2315-2321.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.